MD Anderson Cancer Center has been ranked the second-best cancer hospital in the world in Newsweek’s World’s Best Specialized Hospitals 2027 ranking, recognizing the Houston-based institution’s continued leadership in cancer care, research, and innovation.
The University of Texas MD Anderson Cancer Center ranked No. 2 worldwide in oncology, following Memorial Sloan Kettering Cancer Center and ahead of Gustave Roussy, which ranked third globally.
The annual ranking, developed by Newsweek in partnership with Statista, evaluates specialized hospitals across multiple medical fields. The oncology category considers factors including recommendations from international healthcare professionals, hospital quality indicators, certifications and accreditations, and patient-reported outcome measures.
A Global Leader in Cancer Care
Founded in 1941 and based in Houston, Texas, MD Anderson is one of the world’s largest and most recognized comprehensive cancer centers.
Its mission, “Making Cancer History®,” reflects the institution’s commitment to ending cancer through integrated programs in patient care, research, education, and prevention.
As one of the original comprehensive cancer centers designated by the National Cancer Act of 1971, MD Anderson has played a major role in advancing cancer science and clinical practice for more than eight decades.
Research Driving New Cancer Treatments
Research is at the center of MD Anderson’s approach, with scientists and clinicians working together to develop new strategies for cancer prevention, diagnosis, and treatment.
The institution conducts extensive clinical research programs, including early-phase trials evaluating emerging therapies and treatment approaches.
Major research areas include:
- Immunotherapy and immune-based treatments
- Precision oncology and molecular profiling
- Cell and gene therapies
- Targeted therapies
- Cancer prevention and early detection
- Artificial intelligence and data-driven approaches in oncology
- Through its translational research model, MD Anderson aims to move discoveries from the laboratory into clinical
- practice and make new treatment options available to patients.
Advancing Personalized Cancer Medicine
MD Anderson has been a major contributor to the development of personalized cancer care, using tumor biology and molecular information to help guide treatment decisions.
Its precision oncology programs analyze the unique characteristics of individual cancers to identify potential targeted treatment strategies and support enrollment in clinical trials.
The institution treats patients with a wide range of cancers through specialized multidisciplinary teams, bringing together medical oncologists, surgeons, radiation oncologists, researchers, nurses, and supportive care specialists.
Education and Global Impact
Beyond patient care and research, MD Anderson plays an important role in educating future generations of cancer specialists and researchers.
Through training programs for physicians, scientists, and healthcare professionals, the center contributes to the global oncology workforce.
Its international collaborations and educational initiatives extend its impact beyond Houston, supporting efforts to improve cancer outcomes worldwide.
Continued Recognition Among the World’s Leading Cancer Centers
The Newsweek 2027 ranking adds to MD Anderson’s longstanding recognition as a global leader in oncology.
The institution has also maintained its position as the No. 1 cancer hospital in the United States in U.S. News & World Report’s rankings, reflecting its continued focus on comprehensive cancer care, research innovation, and patient-centered treatment.
Top 10 Cancer Hospitals in the World: Newsweek 2027 Ranking
According to Newsweek’s World’s Best Specialized Hospitals 2027 oncology ranking, the top 10 cancer hospitals worldwide are:
- Memorial Sloan Kettering Cancer Center — New York, United States
- MD Anderson Cancer Center — Houston, United States
- Gustave Roussy — Villejuif, France
- The Royal Marsden Hospital — London, United Kingdom
- Samsung Medical Center — Seoul, South Korea
- Asan Medical Center — Seoul, South Korea
- Mayo Clinic — Rochester, United States
- The Johns Hopkins Hospital — Baltimore, United States
- Dana-Farber Brigham Cancer Center / Brigham and Women’s Hospital — Boston, United States
- Charité – Universitätsmedizin Berlin — Berlin, Germany
MD Anderson’s No. 2 position in the global oncology ranking highlights its continued role as one of the world’s leading institutions dedicated to transforming cancer research and care.
Read further on OncoDaily: Memorial Sloan Kettering Cancer Center Named World’s Best Cancer Hospital in Newsweek 2027 Ranking
